MiNK Therapeutics, Inc. (INKT)

CIK 1840229 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for MiNK Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 202640001193125-26-379524
Sep 2, 202640001193125-26-379522
Sep 2, 202640001193125-26-379575
Sep 2, 202640001193125-26-379513
Sep 2, 202640001193125-26-379518
Aug 13, 2026S-80001193125-26-349328
Aug 13, 20268-K0001193125-26-347907
Aug 13, 202610-Q0001193125-26-349309
Jun 23, 20268-K0001193125-26-278642
Jun 5, 202640001193125-26-260084
Jun 2, 202640001193125-26-253468
Jun 2, 202640001193125-26-253461
Jun 2, 202640001193125-26-253474
Jun 2, 202640001193125-26-253470
Jun 2, 202640001193125-26-253466
May 15, 202610-Q0001193125-26-226804
May 15, 20268-K0001193125-26-225369
Apr 30, 202640001193125-26-197482
Apr 30, 2026DEF 14A0001193125-26-197577
Apr 30, 2026ARS0001193125-26-197583
Apr 9, 202630001193125-26-149642
Mar 31, 202610-K0001193125-26-134813
Mar 31, 20268-K0001193125-26-133346
Mar 27, 20268-K0001193125-26-127931
Mar 23, 202630001193125-26-119823